Medeloop.ai, a healthtech startup hailing from the Stanford University campus, announced that it has raised $8M in seed funding to launch an end-to-end solution for early stage clinical research.

The oversubscribed round was led by General Catalyst with participation from Maven Ventures, the Ovo Fund, NV investments (led by Vivi Nivo), Ken Frazier (former Chairman and CEO of Merck), Dr. Linda Grais (former biotech founder and CEO), and others.